Measles

An illness caused by infection with the measles virus.


Symptoms include fever, tiredness, cough, running nose, inflamed eyes and photophobia (dislike of light). These symptoms usually worsen over three days. Between the third and seventh day, a blotchy rash begins on the forehead, temple and behind the ears, and in 24 to 48 hours, spreads over the entire body.

The rash lasts 4 to 7 days. There may be small white spots on a red base present inside the mouth. Measles usually lasts about 10 days. The cough may be the last symptom to disappear.

Measles is often a severe disease, frequently followed by middle ear infection (2.5% of cases) or bacterial lung infection (4% of cases). In as many as 1 in every 1000 cases brain infection occurs, often resulting in death or permanent brain damage.

Complications from measles are more common and more severe in chronically ill and very young children.


The diagnosis is suspected following a clinical examination and can be confirmed by a blood test.

Measles is spread by mucous membrane (lining of nose and mouth) contact with airborne droplets from the nose and throat caused by coughing and sneezing and by contact with hands, tissues and other articles soiled by nose and throat discharges.

Incubation period

7-18 days; usually 10 days.

Infectious period

From just before the onset of the first symptoms (about 4 days before the rash appears) until 4 days after the rash appears.

Control of spread

Measles is best prevented by the measles-mumps-rubella (MMR) combination vaccine. Two doses of MMR vaccine are recommended: one at twelve months and a booster between 4 to 5 years.

It is also recommended that adults born during or since 1966 should have evidence of having received 2 doses of MMR. Adults born during or since 1966 who do not have evidence of having received 2 doses of MMR vaccine are eligible to access free MMR vaccine via their GP or local Council clinic.

  • If an unimmunised child over 12 months has contact with measles, measles infection can be prevented by immediate vaccination (within 72 hours) with MMR vaccine.
  • If an infant less than 12 months has contact with measles, the chance of developing measles can be reduced by giving immunoglobulin within 7 days of contact. MMR vaccine should then be given as close as possible to 12 months of age but at least 3 months after giving immunoglobulin.
  • A person with measles should be excluded from contact with unvaccinated persons for at least four days after the onset of the rash.
  • Unvaccinated children having contact with a measles case should be excluded for 14 days from the first day of appearance of rash in the last case. If unvaccinated children are vaccinated within 72 hours of their contact with the virus, they may then return to child care, preschool or school.

Treatment
  • No specific antiviral treatment. Complications may require antibiotic therapy.
  • Treatment for the symptoms includes plenty of fluids, a darkened room to rest the eyes and paracetamol, following the directions on the pack, for the fever.

Measles is a notifiable disease.

Adapted from "You’ve got What?", with the permission of the Department of Human Services, South Australia.